Print this page
Monday, 08 February 2016 13:48

Recall - Undeclared Drug Ingredients

Rate this item
(1 Vote)

The National Agency for Food and Drug Administration and Control hereby inform the general public of the voluntary recall of Smart Lipo (800, 900, 950 mg) capsules by SmartLipo365. Smart Lipo is marketed as a dietary supplement and is packaged in bottles of 30 capsules in 800mg, 900mg, and 950mg per capsule. According to FDA certain undeclared ingredients like sibutramine, desmethylsibutramine, and phenolphthalein were discovered in the recently conducted analysis which makes these products unapproved new drugs for which safety and efficacy have not been established. These products if taken concomitantly with other medication may interact in life-threatening manners.

Sibutramine an appetite suppressant is known to increase blood pressure and/or pulse rate in some patients and may pose higher risk effects for patients with heart related health problems. Phenolphthalein is an ingredient previously used in over-the-counter laxatives, but because of concerns of carcinogenicity, it is not currently approved for marketing in the United States. Health risks associated with phenolphthalein could include potentially serious gastrointestinal disturbances, irregular heartbeat, and cancer with long-term use.

NAFDAC implores the members of the public, importers, healthcare providers and consumers to exercise caution in the purchase, administration and use of these products.

NAFDAC…..Safeguarding the health of the Nation!

Read 12935 times Last modified on Wednesday, 18 May 2016 14:16